Verona Pharma American Depositary Share retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-0.528B, a 41.28% increase year-over-year.
Verona Pharma American Depositary Share retained earnings (accumulated deficit) for 2023 were $-0.388B, a 16.61% increase from 2022.
Verona Pharma American Depositary Share retained earnings (accumulated deficit) for 2022 were $-0.333B, a 26.31% increase from 2021.
Verona Pharma American Depositary Share retained earnings (accumulated deficit) for 2021 were $-0.264B, a 27.37% increase from 2020.